lung cancer Archives
Oct. 20, 2016—Vanderbilt-Ingram Cancer Center (VICC) is leading a Phase 3 global trial of a cancer therapy that was initially tested and validated in a VICC research laboratory. One of the first patients treated with the therapy came to VICC after a bump on the head led to an unexpected cancer diagnosis.
Sep. 22, 2016—Jonathan Lehman, M.D., Ph.D., instructor in Medicine in the Division of Hematology/Oncology, has received a Career Development Award from LUNGevity, a nonprofit organization that provides support programs for lung cancer patients and families, public education and funding for innovative scientific research.
Jun. 9, 2016—Vanderbilt University Medical Center has been designated a Lung Cancer Screening Center by the American College of Radiology.
Jan. 27, 2016—A microRNA — a small piece of RNA involved in regulating gene expression — functions as an oncogene to drive the development of lung cancer, Vanderbilt University investigators have discovered.
Jan. 21, 2016—Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been awarded a V Scholar Grant from the V Foundation for Cancer Research.
Jan. 14, 2016—Edward (Ned) Wikle recently celebrated the Christmas holidays with his wife and three young children, a celebration the Jackson, Mississippi-based endodontist, U.S. Navy veteran and cancer patient wasn’t sure he would have.
Nov. 19, 2015—Leora Horn, M.D., M.Sc., associate professor of Medicine and clinical director of the Thoracic Oncology Program at Vanderbilt-Ingram Cancer Center (VICC), has received a 2015 Cancer Clinical Investigator Team Leadership Award (CCITLA) from the National Cancer Institute (NCI).
Jul. 30, 2015—In a town full of amazing singers, Nashville songstress Dawn Sears’ voice was something special.
Jun. 11, 2015—Pierre Massion, M.D., director of the Thoracic Program and an Ingram Professor of Cancer Research at Vanderbilt-Ingram Cancer Center, has been recognized for his pioneering work in lung cancer by the LUNGevity Foundation.
Apr. 2, 2015—Vanderbilt-Ingram Cancer Center investigators have identified the mechanisms used by a gene and its binding protein to drive tumor growth in several forms of cancer, including non-small cell lung cancer.